Business, Management and Accounting
8 years ago

WTO Agreement Limits Developing Countries' Ability to Address Public Health

Palgrave Macmillan UK eBooks
Dealing with Public Health and Intellectual Property for Pharmaceuticals at the World Trade Organization
Valbona Muzaka

Paper Summary

Related papers

Business, Management and Accounting
4 years ago

International Law Fails to Protect Cultural Marks, Leading to Global Theft.

Intellectual Property
Digital Piracy
Intellectual Property
2 views
Business, Management and Accounting
6 years ago

TRIPS Agreement Revolutionizes Intellectual Property Rights Worldwide

Intellectual Property
2 views
Business, Management and Accounting
6 years ago

TRIPS Agreement Revolutionizes Intellectual Property Rights Worldwide

Intellectual Property
2 views

The World Trade Organization (WTO) deals with public health and intellectual property for pharmaceuticals through the TRIPs Agreement. This agreement has been controversial since 1995, especially regarding pharmaceutical patent protection and compulsory licensing. The link between intellectual property rights and trade rules in the WTO limits governments' ability to address public health issues, particularly for developing countries. Compliance with TRIPs provisions requires significant changes to IP laws, especially concerning pharmaceutical intellectual property rights.